$ECYT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDOCYTE INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENDOCYTE INC. Get notifications about new insider transactions in ENDOCYTE INC for free.
Page: < prev 1 2 3 4 5 6 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2018 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Grant | A | 0.00 | 22,500 | 0 | 148,506 | 126 K to 148.5 K (+17.86 %) |
Feb 08 2018 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Payment of Exercise | F | 3.00 | 638 | 1,914 | 126,006 | 126.6 K to 126 K (-0.50 %) |
Feb 08 2018 | ECYT | ENDOCYTE INC | Chelius Erik C. | Vice President CMC | Option Exercise | A | 3.01 | 47,500 | 142,975 | 47,500 | |
Feb 08 2018 | ECYT | ENDOCYTE INC | Chelius Erik C. | Vice President CMC | Grant | A | 0.00 | 16,250 | 0 | 54,409 | 38.2 K to 54.4 K (+42.58 %) |
Feb 08 2018 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Option Exercise | A | 3.01 | 45,000 | 135,450 | 45,000 | |
Feb 08 2018 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Grant | A | 0.00 | 22,500 | 0 | 111,565 | 89.1 K to 111.6 K (+25.26 %) |
Feb 08 2018 | ECYT | ENDOCYTE INC | Andriole Michael T. | Chief Financial Off ... | Option Exercise | A | 3.01 | 50,000 | 150,500 | 50,000 | |
Feb 08 2018 | ECYT | ENDOCYTE INC | Andriole Michael T. | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 150,000 | 125 K to 150 K (+20.00 %) |
Feb 06 2018 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Payment of Exercise | F | 3.12 | 1,736 | 5,416 | 126,644 | 128.4 K to 126.6 K (-1.35 %) |
Feb 06 2018 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Payment of Exercise | F | 3.12 | 1,487 | 4,639 | 128,380 | 129.9 K to 128.4 K (-1.15 %) |
Feb 06 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Payment of Exercise | F | 3.12 | 869 | 2,711 | 59,524 | 60.4 K to 59.5 K (-1.44 %) |
Feb 06 2018 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Payment of Exercise | F | 3.12 | 890 | 2,777 | 60,393 | 61.3 K to 60.4 K (-1.45 %) |
Feb 06 2018 | ECYT | ENDOCYTE INC | Sherman Michael A. | President and CEO | Option Exercise | M | 3.06 | 5,453 | 16,686 | 0 | |
Feb 06 2018 | ECYT | ENDOCYTE INC | Sherman Michael A. | President and CEO | Buy | M | 3.06 | 5,453 | 16,686 | 338,564 | 333.1 K to 338.6 K (+1.64 %) |
Jan 02 2018 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | M | 3.06 | 65,445 | 200,262 | 0 | |
Jan 02 2018 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Gift | G | 0.00 | 8,333 | 0 | 184,985 | 193.3 K to 185 K (-4.31 %) |
Jan 02 2018 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Sell | S | 4.41 | 50,511 | 222,824 | 303,539 | 354.1 K to 303.5 K (-14.27 %) |
Jan 02 2018 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | M | 3.06 | 65,445 | 200,262 | 354,050 | 288.6 K to 354.1 K (+22.68 %) |
Dec 04 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | M | 3.06 | 26,178 | 80,105 | 0 | |
Dec 04 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Sell | S | 5.05 | 5,037 | 25,434 | 127,348 | 132.4 K to 127.3 K (-3.80 %) |
Dec 04 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Sell | S | 5.03 | 18,194 | 91,549 | 132,385 | 150.6 K to 132.4 K (-12.08 %) |
Dec 04 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Buy | M | 3.06 | 26,178 | 80,105 | 150,579 | 124.4 K to 150.6 K (+21.04 %) |
Nov 14 2017 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | P | 4.84 | 5,600 | 27,104 | 288,605 | 283 K to 288.6 K (+1.98 %) |
Nov 14 2017 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Gift | G | 0.00 | 5,600 | 0 | 283,005 | 288.6 K to 283 K (-1.94 %) |
Oct 06 2017 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Grant | A | 0.00 | 30,000 | 0 | 61,283 | 31.3 K to 61.3 K (+95.90 %) |
Oct 06 2017 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Grant | A | 0.00 | 125,000 | 0 | 333,111 | 208.1 K to 333.1 K (+60.06 %) |
Oct 06 2017 | ECYT | ENDOCYTE INC | Parker Katherine | VP of Human Resourc ... | Grant | A | 0.00 | 30,000 | 0 | 63,109 | 33.1 K to 63.1 K (+90.61 %) |
Oct 06 2017 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Grant | A | 0.00 | 40,000 | 0 | 288,605 | 248.6 K to 288.6 K (+16.09 %) |
Oct 06 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Grant | A | 0.00 | 40,000 | 0 | 124,401 | 84.4 K to 124.4 K (+47.39 %) |
Oct 06 2017 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Grant | A | 0.00 | 40,000 | 0 | 89,065 | 49.1 K to 89.1 K (+81.52 %) |
Oct 06 2017 | ECYT | ENDOCYTE INC | Andriole Michael T. | Chief Financial Off ... | Grant | A | 0.00 | 75,000 | 0 | 125,000 | 50 K to 125 K (+150.00 %) |
Jun 02 2017 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Option Exercise | M | 2.10 | 44,285 | 92,999 | 0 | |
Jun 02 2017 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Buy | M | 2.10 | 44,285 | 92,999 | 208,111 | 163.8 K to 208.1 K (+27.03 %) |
May 05 2017 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Grant | A | 0.00 | 3,300 | 0 | 194,049 | 190.7 K to 194 K (+1.73 %) |
May 05 2017 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
May 05 2017 | ECYT | ENDOCYTE INC | APLIN JOHN C | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | APLIN JOHN C | Director | Grant | A | 0.00 | 3,300 | 0 | 28,863 | 25.6 K to 28.9 K (+12.91 %) |
May 05 2017 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Grant | A | 0.00 | 3,300 | 0 | 18,271 | 15 K to 18.3 K (+22.04 %) |
May 05 2017 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
May 05 2017 | ECYT | ENDOCYTE INC | MELDRUM PETER D | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | MELDRUM PETER D | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
May 05 2017 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
May 05 2017 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | A | 2.27 | 19,500 | 44,265 | 19,500 | |
May 05 2017 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Grant | A | 0.00 | 3,300 | 0 | 7,800 | 4.5 K to 7.8 K (+73.33 %) |
Feb 22 2017 | ECYT | ENDOCYTE INC | Andriole Michael T. | Chief Financial Off ... | Option Exercise | A | 2.22 | 100,000 | 222,000 | 100,000 | |
Feb 22 2017 | ECYT | ENDOCYTE INC | Andriole Michael T. | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Feb 07 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Payment of Exercise | F | 2.18 | 694 | 1,513 | 81,901 | 82.6 K to 81.9 K (-0.84 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Payment of Exercise | F | 2.18 | 1,888 | 4,116 | 82,595 | 84.5 K to 82.6 K (-2.23 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Brinkley Michael A. | Vice President of Q ... | Payment of Exercise | F | 2.18 | 578 | 1,260 | 23,486 | 24.1 K to 23.5 K (-2.40 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Brinkley Michael A. | Vice President of Q ... | Payment of Exercise | F | 2.18 | 1,079 | 2,352 | 24,064 | 25.1 K to 24.1 K (-4.29 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Payment of Exercise | F | 2.18 | 692 | 1,509 | 163,826 | 164.5 K to 163.8 K (-0.42 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Payment of Exercise | F | 2.18 | 3,092 | 6,741 | 164,518 | 167.6 K to 164.5 K (-1.84 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Payment of Exercise | F | 2.18 | 935 | 2,038 | 49,065 | 50 K to 49.1 K (-1.87 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Payment of Exercise | F | 2.18 | 694 | 1,513 | 248,605 | 249.3 K to 248.6 K (-0.28 %) |
Feb 07 2017 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Payment of Exercise | F | 2.18 | 1,888 | 4,116 | 249,299 | 251.2 K to 249.3 K (-0.75 %) |
Feb 03 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Feb 03 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Grant | A | 0.00 | 17,500 | 0 | 84,483 | 67 K to 84.5 K (+26.13 %) |
Feb 03 2017 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | A | 2.16 | 35,000 | 75,600 | 35,000 | |
Feb 03 2017 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Grant | A | 0.00 | 17,500 | 0 | 251,187 | 233.7 K to 251.2 K (+7.49 %) |
Feb 03 2017 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | A | 2.16 | 20,000 | 43,200 | 20,000 | |
Feb 03 2017 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Grant | A | 0.00 | 10,000 | 0 | 31,283 | 21.3 K to 31.3 K (+46.99 %) |
Feb 03 2017 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Option Exercise | A | 2.16 | 187,500 | 405,000 | 187,500 | |
Feb 03 2017 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Grant | A | 0.00 | 31,250 | 0 | 167,610 | 136.4 K to 167.6 K (+22.92 %) |
Feb 03 2017 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Option Exercise | A | 2.16 | 40,000 | 86,400 | 40,000 | |
Feb 03 2017 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Grant | A | 0.00 | 20,000 | 0 | 50,000 | 30 K to 50 K (+66.67 %) |
Feb 03 2017 | ECYT | ENDOCYTE INC | Brinkley Michael A. | Vice President of Q ... | Option Exercise | A | 2.16 | 20,000 | 43,200 | 20,000 | |
Feb 03 2017 | ECYT | ENDOCYTE INC | Brinkley Michael A. | Vice President of Q ... | Grant | A | 0.00 | 10,000 | 0 | 25,143 | 15.1 K to 25.1 K (+66.04 %) |
Feb 03 2017 | ECYT | ENDOCYTE INC | Parker Katherine | VP of Human Resourc ... | Option Exercise | A | 2.16 | 25,000 | 54,000 | 25,000 | |
Feb 03 2017 | ECYT | ENDOCYTE INC | Parker Katherine | VP of Human Resourc ... | Grant | A | 0.00 | 12,500 | 0 | 31,609 | 19.1 K to 31.6 K (+65.41 %) |
Jan 04 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | M | 2.10 | 26,178 | 54,974 | 0 | |
Jan 04 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Sell | S | 2.55 | 23,244 | 59,272 | 66,983 | 90.2 K to 67 K (-25.76 %) |
Jan 04 2017 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Buy | M | 2.10 | 26,178 | 54,974 | 90,227 | 64 K to 90.2 K (+40.87 %) |
Nov 16 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | M | 2.10 | 15,706 | 32,983 | 0 | |
Nov 16 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | M | 2.10 | 15,706 | 32,983 | 233,687 | 218 K to 233.7 K (+7.21 %) |
Aug 22 2016 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Option Exercise | A | 3.21 | 22,500 | 72,225 | 22,500 | |
Aug 22 2016 | ECYT | ENDOCYTE INC | Taylor Beth | VP Finance & Chief ... | Grant | A | 0.00 | 3,750 | 0 | 21,283 | 17.5 K to 21.3 K (+21.39 %) |
Jul 28 2016 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Option Exercise | M | 1.91 | 10,471 | 20,000 | 0 | |
Jul 28 2016 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Buy | M | 1.91 | 10,471 | 20,000 | 14,971 | 4.5 K to 15 K (+232.69 %) |
Jun 28 2016 | ECYT | ENDOCYTE INC | Ellis P Ron | Payment of Exercise | F | 3.68 | 13,528 | 49,783 | 320,040 | 333.6 K to 320 K (-4.06 %) | |
Jun 20 2016 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Option Exercise | A | 3.68 | 60,000 | 220,800 | 60,000 | |
Jun 20 2016 | ECYT | ENDOCYTE INC | Sherman Michael A. | President, CEO and ... | Grant | A | 0.00 | 10,000 | 0 | 136,360 | 126.4 K to 136.4 K (+7.91 %) |
May 12 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | P | 3.52 | 11,375 | 40,040 | 217,981 | 206.6 K to 218 K (+5.51 %) |
May 12 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Gift | G | 0.00 | 11,566 | 0 | 206,606 | 218.2 K to 206.6 K (-5.30 %) |
May 06 2016 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | KOZIN MARC D | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
May 06 2016 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
May 06 2016 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | GODDARD COLIN | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
May 06 2016 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
May 06 2016 | ECYT | ENDOCYTE INC | APLIN JOHN C | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | APLIN JOHN C | Director | Grant | A | 0.00 | 2,250 | 0 | 25,563 | 23.3 K to 25.6 K (+9.65 %) |
May 06 2016 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
May 06 2016 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Grant | A | 0.00 | 2,250 | 0 | 203,249 | 201 K to 203.2 K (+1.12 %) |
May 06 2016 | ECYT | ENDOCYTE INC | MELDRUM PETER D | Director | Option Exercise | A | 3.35 | 13,500 | 45,225 | 13,500 | |
May 06 2016 | ECYT | ENDOCYTE INC | MELDRUM PETER D | Director | Grant | A | 0.00 | 2,250 | 0 | 4,500 | 2.3 K to 4.5 K (+100.00 %) |
Feb 18 2016 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | M | 1.91 | 13,089 | 25,000 | 0 | |
Feb 18 2016 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Buy | M | 1.91 | 13,089 | 25,000 | 61,548 | 48.5 K to 61.5 K (+27.01 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Parker Katherine | VP of Human Resourc ... | Option Exercise | A | 3.18 | 37,500 | 119,250 | 37,500 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Parker Katherine | VP of Human Resourc ... | Grant | A | 0.00 | 6,250 | 0 | 17,608 | 11.4 K to 17.6 K (+55.03 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Option Exercise | A | 3.18 | 7,500 | 23,850 | 7,500 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Payment of Exercise | F | 3.02 | 525 | 1,586 | 16,482 | 17 K to 16.5 K (-3.09 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Taylor Beth | Corporate Controlle ... | Grant | A | 0.00 | 3,750 | 0 | 17,007 | 13.3 K to 17 K (+28.29 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Sherman Michael A. | COO and CFO | Option Exercise | A | 3.18 | 86,250 | 274,275 | 86,250 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Sherman Michael A. | COO and CFO | Payment of Exercise | F | 3.02 | 694 | 2,096 | 124,972 | 125.7 K to 125 K (-0.55 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Sherman Michael A. | COO and CFO | Payment of Exercise | F | 3.18 | 1,771 | 5,632 | 125,666 | 127.4 K to 125.7 K (-1.39 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Sherman Michael A. | COO and CFO | Grant | A | 0.00 | 14,375 | 0 | 127,437 | 113.1 K to 127.4 K (+12.71 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | A | 3.18 | 52,500 | 166,950 | 52,500 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Payment of Exercise | F | 3.02 | 695 | 2,099 | 218,172 | 218.9 K to 218.2 K (-0.32 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Payment of Exercise | F | 3.18 | 1,081 | 3,438 | 218,867 | 219.9 K to 218.9 K (-0.49 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Grant | A | 0.00 | 8,750 | 0 | 219,948 | 211.2 K to 219.9 K (+4.14 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Option Exercise | A | 3.18 | 52,500 | 166,950 | 52,500 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Payment of Exercise | F | 3.02 | 695 | 2,099 | 48,459 | 49.2 K to 48.5 K (-1.41 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Payment of Exercise | F | 3.18 | 1,081 | 3,438 | 49,154 | 50.2 K to 49.2 K (-2.15 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Leamon Christopher P | Vice President of R ... | Grant | A | 0.00 | 8,750 | 0 | 50,235 | 41.5 K to 50.2 K (+21.09 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Harper Scot | VP of CLINICAL OPER ... | Option Exercise | A | 3.18 | 52,500 | 166,950 | 52,500 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Harper Scot | VP of CLINICAL OPER ... | Payment of Exercise | F | 3.02 | 694 | 2,096 | 22,535 | 23.2 K to 22.5 K (-2.99 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Harper Scot | VP of CLINICAL OPER ... | Payment of Exercise | F | 3.18 | 1,078 | 3,428 | 23,229 | 24.3 K to 23.2 K (-4.43 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Harper Scot | VP of CLINICAL OPER ... | Grant | A | 0.00 | 8,750 | 0 | 24,307 | 15.6 K to 24.3 K (+56.24 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Option Exercise | A | 3.18 | 161,250 | 512,775 | 161,250 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Payment of Exercise | F | 3.02 | 2,085 | 6,297 | 330,951 | 333 K to 331 K (-0.63 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Payment of Exercise | F | 3.18 | 3,320 | 10,558 | 333,036 | 336.4 K to 333 K (-0.99 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Ellis P Ron | President and CEO | Grant | A | 0.00 | 26,875 | 0 | 336,356 | 309.5 K to 336.4 K (+8.68 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Brinkley Michael A. | VP OF QUALITY | Option Exercise | A | 3.18 | 30,000 | 95,400 | 30,000 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Brinkley Michael A. | VP OF QUALITY | Payment of Exercise | F | 3.02 | 580 | 1,752 | 14,933 | 15.5 K to 14.9 K (-3.74 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Brinkley Michael A. | VP OF QUALITY | Payment of Exercise | F | 3.18 | 618 | 1,965 | 15,513 | 16.1 K to 15.5 K (-3.83 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Brinkley Michael A. | VP OF QUALITY | Grant | A | 0.00 | 5,000 | 0 | 16,131 | 11.1 K to 16.1 K (+44.92 %) |
Feb 08 2016 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Option Exercise | A | 3.18 | 60,000 | 190,800 | 60,000 | |
Feb 08 2016 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
Jan 20 2016 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Buy | P | 2.79 | 10,000 | 27,900 | 200,999 | 191 K to 201 K (+5.24 %) |
Jan 20 2016 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Buy | P | 2.80 | 20,000 | 56,000 | 190,999 | 171 K to 191 K (+11.70 %) |
Dec 28 2015 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Option Exercise | M | 1.91 | 13,089 | 25,000 | 0 | |
Dec 28 2015 | ECYT | ENDOCYTE INC | Low Philip S | Chief Science Offic ... | Buy | M | 1.91 | 13,089 | 25,000 | 211,198 | 198.1 K to 211.2 K (+6.61 %) |
Aug 04 2015 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Option Exercise | A | 5.16 | 60,000 | 309,600 | 60,000 | |
Aug 04 2015 | ECYT | ENDOCYTE INC | Armour Alison A. | Chief Medical Offic ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
May 18 2015 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Option Exercise | A | 6.02 | 13,500 | 81,270 | 13,500 | |
May 18 2015 | ECYT | ENDOCYTE INC | BRAUER KEITH E | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
May 18 2015 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Option Exercise | A | 6.02 | 13,500 | 81,270 | 13,500 | |
May 18 2015 | ECYT | ENDOCYTE INC | Russell Lesley | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
May 18 2015 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Option Exercise | A | 6.02 | 13,500 | 81,270 | 13,500 | |
May 18 2015 | ECYT | ENDOCYTE INC | MIDDLETON FRED A | Director | Grant | A | 0.00 | 2,250 | 0 | 170,999 | 168.7 K to 171 K (+1.33 %) |
May 18 2015 | ECYT | ENDOCYTE INC | HANHAM ANN | Director | Option Exercise | A | 6.02 | 13,500 | 81,270 | 13,500 |